{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:37:31Z","timestamp":1786333051983,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi university young and middle-aged teachers\u2019 basic ability improvement project","award":["2022KY0349"],"award-info":[{"award-number":["2022KY0349"]}]},{"name":"Guangxi Science and technology base and talent project","award":["2022AC21033"],"award-info":[{"award-number":["2022AC21033"]}]},{"name":"The present study was supported by grants from the National Natural Scientific Foundation of China,","award":["82201694, 82003250"],"award-info":[{"award-number":["82201694, 82003250"]}]},{"name":"Development, Promotion and Application Program of Appropriate Health Technologies in Guangxi Province,","award":["S2023125"],"award-info":[{"award-number":["S2023125"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11064-024-04317-3","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T04:57:50Z","timestamp":1735966670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Regulation of Glutamate Transporter Type 1 by TSA and the Antiepileptic Mechanism of TSA"],"prefix":"10.1007","volume":"50","author":[{"given":"Jin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"4317_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","volume":"284","author":"DL Falls","year":"2003","unstructured":"Falls DL et al (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284:14\u201330","journal-title":"Exp Cell Res"},{"issue":"10","key":"4317_CR2","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcp.22609","volume":"226","author":"K Kim","year":"2011","unstructured":"Kim K et al (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226(10):2484\u20132493","journal-title":"J Cell Physiol"},{"key":"4317_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1084\/jem.20160667","volume":"214","author":"L Sha","year":"2017","unstructured":"Sha L et al (2017) Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy. J Exp Med 214:547\u2013563","journal-title":"J Exp Med"},{"key":"4317_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12028-014-0010-z","volume":"21","author":"BF Lin","year":"2014","unstructured":"Lin BF et al (2014) Rosiglitazone attenuates cerebral vasospasm and provides neuroprotection in an experimental rat model of subarachnoid hemorrhage. Neurocrit Care 21:316\u2013331","journal-title":"Neurocrit Care"},{"key":"4317_CR5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/nan.12475","volume":"44","author":"A Hoshi","year":"2018","unstructured":"Hoshi A et al (2018) Altered expression of glutamate transporter-1 and water channel protein aquaporin-4 in human temporal cortex with Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 44:628\u2013638","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1126\/science.276.5319.1699","volume":"276","author":"K Tanaka","year":"1997","unstructured":"Tanaka K et al (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699\u20131702","journal-title":"Science"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.nbd.2012.03.032","volume":"47","author":"Q Kong","year":"2012","unstructured":"Kong Q et al (2012) Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus. Neurobiol Dis 47:145\u2013154","journal-title":"Neurobiol Dis"},{"key":"4317_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbi.2022.07.164","volume":"106","author":"Y Wang","year":"2022","unstructured":"Wang Y, Brain et al (2022) Behav Immun 106:49\u201366","journal-title":"Behav Immun"},{"key":"4317_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13578-022-00814-6","volume":"12","author":"Liping","year":"2022","unstructured":"Liping, Yang et al (2022) Histone deacetylase 3 facilitates TNF\u03b1-mediated NF-\u03baB activation through suppressing CTSB induced RIP1 degradation and is required for host defense against. bacterial Infect Cell Bioscience 12:81","journal-title":"bacterial Infect Cell Bioscience"},{"key":"4317_CR10","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1007\/s00018-014-1656-6","volume":"71","author":"Jing","year":"2014","unstructured":"Jing, Zhang et al (2014) Histone deacetylase inhibitors and cell death(Review). Cell Mol Life Sci 71:3885\u20133901","journal-title":"Cell Mol Life Sci"},{"key":"4317_CR11","doi-asserted-by":"crossref","unstructured":"Jingzi, He et al (2014) Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts. Cell Neurosci 13(8):382","DOI":"10.3389\/fncel.2014.00382"},{"key":"4317_CR12","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1134\/S0022093023050228","volume":"59","author":"AN Tursunov","year":"2023","unstructured":"Tursunov AN et al (2023) Molecular Mechanisms of Valproic Acid Action on Signalling Systems and Brain Functions. J Evol Biochem Physiol 59:1740\u20131755","journal-title":"J Evol Biochem Physiol"},{"key":"4317_CR13","doi-asserted-by":"crossref","unstructured":"Thiagalingam S et al (2003) Histone deacetylases: Unique players in shaping the epigenetic histone code, vol 983. Annals of the New York Academy of Sciences, pp 84\u2013100","DOI":"10.1111\/j.1749-6632.2003.tb05964.x"},{"key":"4317_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1530-0277.2011.01581.x","volume":"36","author":"AJ Sakharkar","year":"2012","unstructured":"Sakharkar AJ et al (2012) Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res 36:61\u201371","journal-title":"Alcohol Clin Exp Res"},{"key":"4317_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12031-012-9842-1","volume":"49","author":"M Itoh","year":"2013","unstructured":"Itoh M et al (2013) Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation. J Mol Neurosci 49:21\u201327","journal-title":"J Mol Neurosci"},{"issue":"3","key":"4317_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972) Modifcation of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281\u2013294","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"4317_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/syn.20947","volume":"65","author":"M Shibasaki","year":"2011","unstructured":"Shibasaki M et al (2011) Enhancement of histone acetylation in midbrain of mice with ethanol physical dependence and its withdrawal. Synapse 65:1244\u20131250","journal-title":"Synapse"},{"issue":"2","key":"4317_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nbd.2008.07.003","volume":"32","author":"Campbell","year":"2008","unstructured":"Campbell et al (2008) Hablitz. Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia. Neurobiol Dis 32(2):254\u2013261","journal-title":"Neurobiol Dis"},{"key":"4317_CR19","doi-asserted-by":"crossref","unstructured":"Lopes MW et al (2013) Time-dependent modulation of AMPA receptor phosphorylation and mRNA expression of NMDA receptors and glial glutamate transporters in the rat hippocampus and cerebral cortex in a pilocarpine model of epilepsy. Exp Brain Res 226(2):153\u2013163","DOI":"10.1007\/s00221-013-3421-8"},{"key":"4317_CR20","doi-asserted-by":"publisher","first-page":"10588","DOI":"10.1523\/JNEUROSCI.2323-09.2009","volume":"29","author":"Y David","year":"2009","unstructured":"David Y et al (2009) Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J Neurosci 29:10588\u201310599","journal-title":"J Neurosci"},{"key":"4317_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.10648","volume":"54","author":"M Wong","year":"2003","unstructured":"Wong M et al (2003) Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 54:251\u2013256","journal-title":"Ann Neurol"},{"key":"4317_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00221-007-0954-8","volume":"181","author":"Y Ueda","year":"2007","unstructured":"Ueda Y et al (2007) Functional role for redox in the epileptogenesis: molecular regulation of glutamate in the hippocampus of FeCl3-induced limbic epilepsy model. Exp Brain Res 181:571\u2013577","journal-title":"Exp Brain Res"},{"key":"4317_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ana.20380","volume":"57","author":"I Cavus","year":"2005","unstructured":"Cavus I et al (2005) M.Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol 57:226\u2013235","journal-title":"Ann Neurol"},{"key":"4317_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1212\/01.WNL.0000149636.44660.99","volume":"64","author":"WS van der Hel","year":"2005","unstructured":"van der Hel WS et al (2005) Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology 64:326\u2013333","journal-title":"Neurology"},{"key":"4317_CR25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1179\/174313208X327964","volume":"30","author":"Z Lu","year":"2008","unstructured":"Lu Z et al (2008) The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative study. Neurol Res 30:915\u2013919","journal-title":"Neurol Res"},{"issue":"1","key":"4317_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65(1):1\u2013105","journal-title":"Prog Neurobiol"},{"issue":"3 Pt 1","key":"4317_CR27","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1523\/JNEUROSCI.15-03-01835.1995","volume":"15","author":"KP Lehre","year":"1995","unstructured":"Lehre KP et al (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15(3 Pt 1):1835\u20131853","journal-title":"J Neurosci"},{"issue":"24","key":"4317_CR28","doi-asserted-by":"publisher","first-page":"9607","DOI":"10.3390\/ijms21249607","volume":"21","author":"C Alison","year":"2020","unstructured":"Alison C, Todd et al (2020) The Regulation of Astrocytic Glutamate Transporters in Health and Disease. Int J Mol Sci 21(24):9607","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4317_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00232-015-9826-5","volume":"248","author":"Abeer","year":"2015","unstructured":"Abeer, Abousaab et al (2015) Down-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by the Kinases SPAK and OSR1. J Membr Biol 248(6):1107\u20131119","journal-title":"J Membr Biol"},{"key":"4317_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3389\/fneur.2020.01006","volume":"11","author":"R Allison","year":"2020","unstructured":"Allison R, Peterson et al (2020) Astrocyte Glutamate Uptake and Signaling as Novel Targets for Neurological Disease Treatment. Front Neurol 11:1006","journal-title":"Front Neurol"},{"issue":"4","key":"4317_CR31","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","volume":"93","author":"RJ Van denberg","year":"2013","unstructured":"Van denberg RJ et al (2013) Mechanisms of glutamate transport. Physiol Rev 93(4):1621\u20131657","journal-title":"Physiol Rev"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04317-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04317-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04317-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:05:53Z","timestamp":1738411553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04317-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04317-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of Guangxi University of Science and Technology (approval number: DWLL2024051).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"74"}}